Protection and Pathology in Leishmania braziliensis Infection

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis

(2021) Andréa Magalhães et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis

(2021) Walker N. Oliveira et al.   Frontiers in Cellular and Infection Microbiology

Blockade of TLR2 and TLR4 Attenuates Inflammatory Response and Parasite Load in Cutaneous Leishmaniasis

(2021) Pedro Paulo Carneiro et al.   Frontiers in Immunology

Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis

(2020) Augusto M Carvalho et al.   JOURNAL OF INFECTIOUS DISEASES

Granzyme B inhibition by tofacitinib blocks pathology induced by CD8 T cells in cutaneous leishmaniasis

(2020) Fernanda O. Novais et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil

(2020) Paulo R L Machado et al.   CLINICAL INFECTIOUS DISEASES

Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis

(2020) Carolina Cattoni Koh et al.   Frontiers in Immunology

Circulating Senescent T Cells Are Linked to Systemic Inflammation and Lesion Size During Human Cutaneous Leishmaniasis

(2019) Luciana P. Covre et al.   Frontiers in Immunology

Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection

(2019) Augusto M. Carvalho et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients

(2018) Silvana C. Silva et al.   ACTA TROPICA

Association of Treatment of American Cutaneous Leishmaniasis Prior to Ulcer Development with High Rate of Failure in Northeastern Brazil

(2018) Alon Unger et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Mannose receptor high, M2 dermal macrophages mediate nonhealingLeishmania majorinfection in a Th1 immune environment

(2017) Sang Hun Lee et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy

(2017) Rúbia S Costa et al.   JOURNAL OF INFECTIOUS DISEASES

Cytotoxic activity in cutaneous leishmaniasis

(2017) Taís M Campos et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production

(2017) Fernanda O. Novais et al.   PLoS Pathogens

Immunologic Markers of Protection inLeishmania (Viannia) braziliensisInfection: A 5-Year Cohort Study

(2016) Aline C. Muniz et al.   JOURNAL OF INFECTIOUS DISEASES

Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects

(2016) Luiz Henrique Guimarães et al.   PLoS Neglected Tropical Diseases

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis

(2016) Pedro Paulo Carneiro et al.   PLoS One

The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis

(2014) Walker Nonato Oliveira et al.   CYTOKINE

Protective and Pathological Functions of CD8+T Cells in Leishmania braziliensis Infection

(2014) Thiago Marconi Cardoso et al.   INFECTION AND IMMUNITY

Intermediate Monocytes Contribute to Pathologic Immune Response inLeishmania braziliensisInfections

(2014) Sara Passos et al.   JOURNAL OF INFECTIOUS DISEASES

Human Classical Monocytes Control the Intracellular Stage of Leishmania braziliensis by Reactive Oxygen Species

(2014) Fernanda O. Novais et al.   JOURNAL OF INFECTIOUS DISEASES

Cytotoxic T Cells Mediate Pathology and Metastasis in Cutaneous Leishmaniasis

(2013) Fernanda O. Novais et al.   PLoS Pathogens

Association between an Emerging Disseminated form of Leishmaniasis and Leishmania (Viannia) braziliensis Strain Polymorphisms

(2012) A. Queiroz et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A proposed new clinical staging system for patients with mucosal leishmaniasis

(2012) Hélio A. Lessa et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends

(2012) Ali Badiee et al.   VACCINE

IFN-γ Production to Leishmania Antigen Supplements the Leishmania Skin Test in Identifying Exposure to L. braziliensis Infection

(2012) Daniel Schnorr et al.   PLoS Neglected Tropical Diseases

Protective and pathologic immune responses in human tegumentary leishmaniasis

(2012) Lucas P. Carvalho et al.   Frontiers in Immunology

Human mucosal leishmaniasis: Neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines

(2010) Viviane S. Boaventura et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Interleukin 17 Production among Patients with American Cutaneous Leishmaniasis

(2009) Olívia Bacellar et al.   JOURNAL OF INFECTIOUS DISEASES

Recruitment of CD8+T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis

(2009) D. R. FARIA et al.   PARASITE IMMUNOLOGY

Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil

(2009) L.H. Guimarães et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE